Citation: | Mao Kaifeng, Luo Jialiang, Lin Fenwang, et al. Effect and mechanism of terminal fucosylation inhibitor on ciclosporin-induced renal epithelial-mesenchymal transition[J]. ORGAN TRANSPLANTATION, 2022, 13(5): 626-633. doi: 10.3969/j.issn.1674-7445.2022.05.012 |
[1] |
PATOCKA J, NEPOVIMOVA E, KUCA K, et al. Cyclosporine A: chemistry and toxicity - a review[J]. Curr Med Chem, 2021, 28(20): 3925-3934. DOI: 10.2174/0929867327666201006153202.
|
[2] |
STÂRCEA M, GAVRILOVICI C, MUNTEANU M, et al. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome[J]. J Int Med Res, 2018, 46(3): 1172-1177. DOI: 10.1177/0300060517746559.
|
[3] |
LIN CX, LI Y, LIANG S, et al. Metformin attenuates cyclosporine A-induced renal fibrosis in rats[J]. Transplantation, 2019, 103(10): e285-e296. DOI: 10.1097/TP.0000000000002864.
|
[4] |
CHEN Y, WANG N, YUAN Q, et al. The protective effect of fluorofenidone against cyclosporine A-induced nephrotoxicity[J]. Kidney Blood Press Res, 2019, 44(4): 656-668. DOI: 10.1159/000500924.
|
[5] |
WELLENS S, DEHOUCK L, CHANDRASEKARAN V, et al. Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound[J]. Toxicol In Vitro, 2021, 73: 105112. DOI: 10.1016/j.tiv.2021.105112.
|
[6] |
TAN YC, ABDUL SATTAR M, AHMEDA AF, et al. Apocynin and catalase prevent hypertension and kidney injury in cyclosporine A-induced nephrotoxicity in rats[J]. PLoS One, 2020, 15(4): e0231472. DOI: 10.1371/journal.pone.0231472.
|
[7] |
PHAN K, CHARLTON O, BAKER C, et al. Dermatologist attitudes toward ciclosporin use in atopic dermatitis[J]. J Dermatolog Treat, 2021, 32(8): 922-924. DOI: 10.1080/09546634.2020.1724251.
|
[8] |
HOŠKOVÁ L, MÁLEK I, KOPKAN L, et al. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension[J]. Physiol Res, 2017, 66(2): 167-180. DOI: 10.33549/physiolres.933332.
|
[9] |
PONTICELLI C, GLASSOCK RJ. Prevention of complications from use of conventional immunosuppressants: a critical review[J]. J Nephrol, 2019, 32(6): 851-870. DOI: 10.1007/s40620-019-00602-5.
|
[10] |
NAGAVALLY RR, SUNILKUMAR S, AKHTAR M, et al. Chrysin ameliorates cyclosporine-A-induced renal fibrosis by inhibiting TGF-β1-induced epithelial-mesenchymal transition[J]. Int J Mol Sci, 2021, 22(19): 10252. DOI: 10.3390/ijms221910252.
|
[11] |
WU Q, WANG X, NEPOVIMOVA E, et al. Mechanism of cyclosporine A nephrotoxicity: oxidative stress, autophagy, and signalings[J]. Food Chem Toxicol, 2018, 118: 889-907. DOI: 10.1016/j.fct.2018.06.054.
|
[12] |
GROENENDYK J, ROBINSON A, WANG Q, et al. Tauroursodeoxycholic acid attenuates cyclosporine-induced renal fibrogenesis in the mouse model[J]. Biochim Biophys Acta Gen Subj, 2019, 1863(7): 1210-1216. DOI: 10.1016/j.bbagen.2019.04.016.
|
[13] |
FANG M, KANG L, WANG X, et al. Inhibition of core fucosylation limits progression of diabetic kidney disease[J]. Biochem Biophys Res Commun, 2019, 520(3): 612-618. DOI: 10.1016/j.bbrc.2019.10.037.
|
[14] |
YU A, ZHAO J, ZHONG J, et al. Altered O-glycomes of renal brush-border membrane in model rats with chronic kidney diseases[J]. Biomolecules, 2021, 11(11): 1560. DOI: 10.3390/biom11111560.
|
[15] |
LIU A, WANG X, HU X, et al. Core fucosylation involvement in the paracrine regulation of proteinuria-induced renal interstitial fibrosis evaluated with the use of a microfluidic chip[J]. Acta Biomater, 2022, 142: 99-112. DOI: 10.1016/j.actbio.2022.02.020.
|
[16] |
LI J, HSU HC, MOUNTZ JD, et al. Unmasking fucosylation: from cell adhesion to immune system regulation and diseases[J]. Cell Chem Biol, 2018, 25(5): 499-512. DOI: 10.1016/j.chembiol.2018.02.005.
|
[17] |
MEHTA K, PATEL K, PANDYA S, et al. Altered mRNA expression of fucosyltransferases and fucosidase predicts prognosis in human oral carcinoma[J]. Int J Mol Cell Med, 2021, 10(2): 123-131. DOI: 10.22088/IJMCM.BUMS.10.2.123.
|
[18] |
PARK S, LIM JM, CHUN JN, et al. Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non small cell lung cancer[J]. Int J Oncol, 2020, 56(2): 559-567. DOI: 10.3892/ijo.2019.4953.
|
[19] |
LAI TY, CHEN IJ, LIN RJ, et al. Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells[J]. Cell Death Discov, 2019, 5: 74. DOI: 10.1038/s41420-019-0145-y.
|
[20] |
LOONG JH, WONG TL, TONG M, et al. Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma[J]. J Clin Invest, 2021, 131(11): e143377. DOI: 10.1172/JCI143377.
|
[21] |
HAN C, JIANG YH, LI W, et al. Astragalus membranaceus and salvia miltiorrhiza ameliorates cyclosporin A-induced chronic nephrotoxicity through the "gut-kidney axis"[J]. J Ethnopharmacol, 2021, 269: 113768. DOI: 10.1016/j.jep.2020.113768.
|
[22] |
XIA Z, ZHANG C, GUO C, et al. Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway[J]. Acta Biomater, 2022, 144: 42-53. DOI: 10.1016/j.actbio.2022.03.024.
|
[23] |
LI R, GUO Y, ZHANG Y, et al. Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4/NF-κB and MAPK signaling pathways[J]. Int J Mol Sci, 2019, 20(5): 1103. DOI: 10.3390/ijms20051103.
|
[24] |
BAI Y, WANG W, YIN P, et al. Ruxolitinib alleviates renal interstitial fibrosis in UUO mice[J]. Int J Biol Sci, 2020, 16(2): 194-203. DOI: 10.7150/ijbs.39024.
|
[25] |
GENG XQ, MA A, HE JZ, et al. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways[J]. Acta Pharmacol Sin, 2020, 41(5): 670-677. DOI: 10.1038/s41401-019-0324-7.
|
[26] |
HUANG J, YAO X, WENG G, et al. Protective effect of curcumin against cyclosporine A induced rat nephrotoxicity[J]. Mol Med Rep, 2018, 17(4): 6038-6044. DOI: 10.3892/mmr.2018.8591.
|
[27] |
FUJITA K, HATANO K, HASHIMOTO M, et al. Fucosylation in urological cancers[J]. Int J Mol Sci, 2021, 22(24): 13333. DOI: 10.3390/ijms222413333.
|
[28] |
SHAN M, YANG D, DOU H, et al. Fucosylation in cancer biology and its clinical applications[J]. Prog Mol Biol Transl Sci, 2019, 162: 93-119. DOI: 10.1016/bs.pmbts.2019.01.002.
|
[29] |
ZHANG B, CHEN X, RU F, et al. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis[J]. Cell Death Dis, 2021, 12(9): 843. DOI: 10.1038/s41419-021-04137-1.
|
[30] |
SHEN H, HE Q, DONG Y, et al. Upregulation of miRNA-1228-3p alleviates TGF-β-induced fibrosis in renal tubular epithelial cells[J]. Histol Histopathol, 2020, 35(10): 1125-1133. DOI: 10.14670/HH-18-242.
|
[31] |
DENG G, CHEN L, ZHANG Y, et al. Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-β/Smad signaling pathway in lung adenocarcinaoma[J]. Exp Cell Res, 2018, 370(2): 613-622. DOI: 10.1016/j.yexcr.2018.07.026.
|